The telomere hypothesis postulates stabilization of telomere length and telomerase activationas key events in cellular immortalization and carcinogeneses. Accordingly, telomerase has been suggestedas a novel and highly selective target for design of antitumor drugs. Screening of a chemical libraryincluding 16 000 synthetic compounds yielded six that strongly inhibited telomerase activity in extractsof cultured human cells, including four isothiazolone derivatives and two unrelated compounds. The mostpotent inhibitor was 2-[3-(trifluoromethyl)phenyl]isothiazolin-3-one (TMPI), a concentration of 1.0
Minhibited telomerase activity by 50% according to a telomere repeat amplification protocol (TRAP) assay.Analysis using partially purified telomerase from AH7974 rat hepatoma cells demonstrated noncompetitiveinhibition with the telomere-repeat primer and mixed inhibition with the dNTPs; the inhibition constantwas 2.5
M. TMPI did not inhibit eukaryotic DNA polymerase
,
, or human immunodeficiency virusreverse transcriptase (HIV RT). Thus, inhibition by TMPI was highly selective for telomerase. Inhibitionby TMPI was quenched by 1 mM of dithiothreitol or glutathione, suggesting that TMPI inhibits telomeraseby acting at a cystein residue. TMPI inhibition of this enzyme may find application as an antineoplasticagent.